https://clinicaltrials.gov/ct2/show/NCT03444064
PolyTreg Immunotherapy in Islet Transplantation
Study Type : Interventional
Estimated Enrollment : 18 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Polyclonal Regulatory T Cell (PolyTreg) Immunotherapy in Islet Transplantation
Actual Study Start Date : February 1, 2018
Estimated Primary Completion Date : March 2020
Estimated Study Completion Date : March 2021